Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ACHE | P22303 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.35 |
| ▸ | NPC1 | O15118 | 4/20 | 0.35 |
| ▸ | RAB9A | P51151 | 4/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.35 |
| ▸ | NFKB2 | Q00653 | 2/20 | 0.35 |
| ▸ | RELA | Q04206 | 2/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | POLB | P06746 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.34 |
| ▸ | CES1 | P23141 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 3/20 | 0.33 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.33 |
| ▸ | HKDC1 | Q2TB90 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL503495 | 0.98 | TSHR (0.40) | TSHRACHELMNAALOX12HPGD | |
| Tetraphenylphosphonium SCHEMBL23455574 | 0.98 | TSHR (0.40) | TSHRACHELMNAALOX12HPGD | |
| Tetraphenylphosphonium SCHEMBL31277980 | 0.98 | TSHR (0.40) | TSHRACHELMNAALOX12HPGD | |
| SCHEMBL4387940 | 0.91 | TSHR (0.42) | TSHRACHELMNAALOX12HPGD | |
| SCHEMBL29404005 | 0.84 | ACHE (0.53) | TSHRACHELMNAALOX12HPGD | |
| SCHEMBL7034016 | 0.84 | ACHE (0.53) | TSHRACHELMNAALOX12HPGD | |
| Tetraphenylphosphonium SCHEMBL15070 | 0.84 | HIF1A (0.38) | HPGDSMN1; SMN2MAPTALDH1A1HIF1A | |
| SCHEMBL5909841 | 0.84 | ACHE (0.53) | TSHRACHELMNAALOX12HPGD | |
| Iodide SCHEMBL7065210 | 0.81 | LMNA (0.50) | TSHRACHELMNAALOX12HPGD | |
| SCHEMBL21810715 | 0.81 | ACHE (0.50) | TSHRACHELMNAALOX12HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 740 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108864413-B | Epoxy resin composition and semiconductor device | 信越化学工业株式会社 | 2022-10-21 | — | — | CN | claimed |
| EP-3401346-B1 | EPOXY RESIN COMPOSITION AND SEMICONDUCTOR DEVICE | SHINETSU CHEMICAL CO (JP) | 2021-06-30 | — | — | EP | claimed |
| US-20180327542-A1 | EPOXY RESIN COMPOSITION AND SEMICONDUCTOR DEVICE | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2018-11-15 | — | — | US | claimed |
| EP-3401346-A1 | EPOXY RESIN COMPOSITION AND SEMICONDUCTOR DEVICE | Shin-Etsu Chemical Co., Ltd. (JP) | 2018-11-14 | — | — | EP | claimed |
| US-9983162-B2 | Method and device for detection of bioavailable drug concentration | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2018-05-29 | — | — | US | claimed |
| US-20150119848-A1 | METHOD AND DEVICE FOR DETECTION OF BIOAVAILABLE DRUG CONCENTRATION | THE GOVERNMENT OF THE UNITED STATES, AS REPRESENTED BY THE SECRETARY OF THE ARMY | 2015-04-30 | — | — | US | claimed |
| EP-2856133-A1 | IMPROVED METHOD AND DEVICE FOR DETECTION OF BIOAVAILABLE DRUG CONCENTRATION | The University of Tennessee Research Foundation (US) | 2015-04-08 | — | — | EP | claimed |
| WO-2013180814-A1 | IMPROVED METHOD AND DEVICE FOR DETECTION OF BIOAVAILABLE DRUG CONCENTRATION | THE UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION (US) | 2013-12-05 | — | — | WO | claimed |
| US-8269213-B2 | Epoxy resin composition for semiconductor encapsulation and semiconductor device produced by using the same | NITTO DENKO CORPORATION (JP) | 2012-09-18 | — | — | US | claimed |
| US-20260146153-A1 | RESIN COMPOSITION FOR MOLDING AND ELECTRONIC COMPONENT DEVICE | RESONAC CORPORATION (JP) | 2026-05-28 | — | — | US | disclosed |
| WO-2026100731-A1 | COMPOSITION FOR OPTICAL MATERIAL, POLYMERIZABLE COMPOSITION FOR OPTICAL MATERIAL, OPTICAL MATERIAL, AND LENS | 三井化学株式会社 | 2026-05-15 | — | — | WO | disclosed |
| US-20260132243-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RESONAC CORP (JP) | 2026-05-14 | — | — | US | disclosed |
| US-20260123505-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND WIRING BOARD | RESONAC CORP (JP) | 2026-04-30 | — | — | US | disclosed |
| EP-4410859-B1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTO-MELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RESONAC CORP (JP) | 2026-04-29 | — | — | EP | disclosed |
| EP-1701400-A1 | Conductive epoxy resin composition and separator for fuel cell | NICHIAS CORPORATION (JP) | 2006-09-13 | — | — | EP | disclosed |
| EP-1538182-B1 | Method for producing epoxy resin composition for semiconductor encapsulation and epoxy resin composition for semiconductor encapsulation and semiconductor device obtained thereby | NITTO DENKO CORP (JP) | 2006-09-06 | — | — | EP | disclosed |
| US-20050154152-A1 | Mixing an epoxy resin, a phenol resin, and a hardening accelerator, under a reduced pressure and under a heating condition and then mixing | NITTO DENKO CORPORATION | 2005-07-14 | — | — | US | disclosed |
| EP-1538182-A1 | Method for producing epoxy resin composition for semiconductor encapsulation and epoxy resin composition for semiconductor encapsulation and semiconductor device obtained thereby | NITTO DENKO CORPORATION (JP) | 2005-06-08 | — | — | EP | disclosed |
| JP-2003292581-A | CURING ACCELERATOR FOR EPOXY RESIN | HOKKO CHEM IND CO LTD | 2003-10-15 | — | — | JP | disclosed |
| JP-2003020326-A | CURING ACCELERATOR FOR EPOXY RESIN AND LIQUID EPOXY RESIN COMPOSITION | HOKKO CHEM IND CO LTD | 2003-01-24 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260123505-A1 | METHOD FOR MANUFACTURING SEMICONDUCTOR DEVICE, AND WIRING BOARD | SEM1, CDH1, PUF60 | TSHR 779/4885ACHE 2062/4885LMNA 1279/4885 |
| US-20260146153-A1 | RESIN COMPOSITION FOR MOLDING AND ELECTRONIC COMPONENT DEVICE | MYB, EED, RPS27L | TSHR 4733/4885ACHE 2996/4885LMNA 801/4885 |
| US-20260132243-A1 | THERMOSETTING COMPOSITION AND CURED PRODUCT THEREOF, PHOTOMELTABLE COMPOSITION, AND STRUCTURAL BODY PRODUCTION METHOD | RER1, OXTR, MAP1LC3A | TSHR 1945/4885ACHE 4351/4885LMNA 2965/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.